For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Oxyclozanide is a salicylanilide anthelmintic. It is used in the treatment and control of fascioliasis in ruminants mainly domestic animals such as cattle, sheep, and goats. It mainly acts by uncoupling of oxidative phosphorylation in flukes.
Scope of the Report:
In 2016, the global oxyclozanide market is led by Africa, capturing about 27.36% of global oxyclozanide consumption. India is the second-largest region-wise market with 28.08% global sales share. At present, the major leader manufacturers of oxyclozanide are concentrated in India.
Africa was the largest regional market for oxyclozanide, with revenue exceeding USD 4.85 million in 2016. It is further expected still to grow due to downstream demand. In the past time, the global feed market has maintained a more stable growth rate. Africa, China, Latin America have maintained a rapid growth rate. The North American market is stagnant. In the foreseeable future, the growth of this industry mainly comes from the growth of these areas.
In application, oxyclozanide downstream is wide and recently feed additives has acquired increasing significance in various fields of Cattle Feeds, Cattle Feeds, Sheep Feeds, pig feeds and other feeds. Globally, the feed additives market is mainly driven by growing demand for Swine Feeds which accounts for nearly 31.6% of total downstream consumption of feed additives in global.
In the future, global market is expected to witness stable growth on account of rising applications, so in the next few years, oxyclozanide production will show a trend of steady growth. In 2023 the production of f oxyclozanide is estimated to be 1230.0 MT. On product prices, the slow downward trend in recent years will maintain in the future.
The worldwide market for Oxyclozanide is expected to grow at a CAGR of roughly 10.0% over the next five years, will reach 34 million US$ in 2024, from 19 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Oxyclozanide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Siflon Drugs
- Yabang
- Gharda
- ASCENT PHARMA
- Aarambh Life Science
- ProVentus
- Excel Industries
- Konar Organics
- Neha Pharma
- D. H. Organics
- Neeta Interchem
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Content 98%
- Content 99%
- Other
Market Segment by Applications, can be divided into
- Injectables
- Oral Liquids
- Feed Additives
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oxyclozanide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oxyclozanide, with price, sales, revenue and global market share of Oxyclozanide in 2017 and 2018.
Chapter 3, the Oxyclozanide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oxyclozanide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Oxyclozanide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Oxyclozanide sales channel, distributors, customers, research findings and conclusion, appendix and data source.